SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-058160
Filing Date
2023-12-18
Accepted
2023-12-18 16:30:24
Documents
16
Period of Report
2023-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20016811_8k.htm   iXBRL 8-K 42994
2 EXHIBIT 10.1 ef20016811_ex10-1.htm EX-10.1 1336167
3 EXHIBIT 10.2 ef20016811_ex10-2.htm EX-10.2 158498
4 EXHIBIT 99.1 ef20016811_ex99-1.htm EX-99.1 15456
8 image001.jpg GRAPHIC 7448
  Complete submission text file 0001140361-23-058160.txt   1998437

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA adma-20231218.xsd EX-101.SCH 3881
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20231218_lab.xml EX-101.LAB 22547
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20231218_pre.xml EX-101.PRE 16055
10 EXTRACTED XBRL INSTANCE DOCUMENT ef20016811_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 231494166
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)